CHRONISCH ZIEKEN
, Robyn Bruins Case Study 3
Inhoudsopgave
Casus......................................................................................................................................................2
Gevalsbeschrijving..................................................................................................................................4
Voorgeschiedenis...............................................................................................................................4
Prevalentie en incidentie....................................................................................................................4
Pathofysiologie...................................................................................................................................4
Beloop................................................................................................................................................4
Gevolgen voor het functioneren.........................................................................................................4
ICF..........................................................................................................................................................4
Aandoeningen/ziekten.......................................................................................................................4
Anatomische eigenschappen..............................................................................................................5
Functies..............................................................................................................................................5
Activiteiten.........................................................................................................................................5
Participatie.........................................................................................................................................5
Externe factoren.................................................................................................................................5
Persoonlijke factoren..........................................................................................................................5
Ethische/Juridische aspecten..............................................................................................................5
Verpleegkundige diagnosen...................................................................................................................5
Beleid en taakverdeling..........................................................................................................................6
Gezondheidsprobleem...........................................................................................................................6
Methoden...............................................................................................................................................6
Verdieping..............................................................................................................................................7
Figuur 1: Flowchart verworven artikelen........................................................................................7
Tabel1: Overzicht verworven literatuur..........................................................................................8
Tabel 2: Checklist verworven literatuur..........................................................................................9
Interventies............................................................................................................................................9
Sinaasappelsap met plant-sterolen....................................................................................................9
Gepersonaliseerde webbased interventie met leefstijladvies en persoonlijke begeleiding...............9
Voedingssupplement NutraforChol® met rode-gistextract.................................................................9
Aanvullend praktijkonderzoek: Enquête Patiënt................................................................................9
Tabel 3: Overzicht effectiviteit interventies beschreven in verworven literatuur.........................10
RR: Risk Reduction........................................................................................................................10
Bespreking............................................................................................................................................10
Effect................................................................................................................................................10
Bewijs...............................................................................................................................................10
1